Prevention and protective adjuvant treatment for actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC).
Reduces and improves the subclinical cutaneous cancerisation field associated with actinic keratosis and non-melanoma skin cancer.
HOW TO USE
Apply liberally to the affected area twice a day, in the morning and at midday. Photolyase is activated by visible light.